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he Study of the Liver. Published bSummary Background/Aims: Most benign gastric ulcers are healed through suppression of
gastric acid by a proton pump inhibitor (PPI). Despite prolonged use of a PPI, some gastric ul-
cers still do not heal. The primary goal of this study is to investigate the relationship between
the expression of connexin 32 (Cx32), a major gap junction protein expressed in the gastric mu-
cosa, and the healing response of gastric ulcers.
Methods: Patients with endoscopically verified gastric ulcer were treated with a standard dose
of PPI for 12 weeks. Histological studies were performed to exclude malignancy. In total, 10
patients having endoscopically verified gastric ulcers with delayed healing at the end of the
PPI course were included in this study. The control group consisted of 11 patients with gastric
ulcers that healed normally. The expression of Cx32 in the gastric mucosa of the ulcer margin
was analyzed by immunoblotting.
Results: Patients with gastric ulcer showing delayed healing had significantly reduced Cx32
expression in the gastric mucosa compared with the patients in whom the ulcers healed nor-
mally (i.e., controls). Age, sex, presence of duodenal ulcers, location and size of gastric ulcer,
ulcer staging, Helicobacter pylori infection, use of nonsteroidal anti-inflammatory drugs
(NSAIDs) and aspirin, smoking, and alcohol consumption were similar in both the control and
delayed healing groups. H. pylori infection, use of NSAIDs, smoking, and alcohol consumption
all had no significant impacts on the expression of Cx32. Age and expression of Cx32 were not
correlated.astroenterology, Department of Medicine, Mackay Memorial Hospital, Number 92, Section 2, Chung-
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delayed healing in patients with gastric ulcer following acid-suppression therapy.
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The pathogenesis of gastric ulcer involves the interplay
between injuries, defense, and repair of the gastric mu-
cosa, as it is constantly exposed to a harmful environment.
The chronic nature of gastric ulcers has been described to
be associated with the size of the ulcer [1], smoking [2],
persistence of Helicobacter pylori infection [3], continued
use of nonsteroidal anti-inflammatory drugs (NSAIDs) [4],
and an impaired response to antisecretory agents [5].
Suppressing acid secretion is the mainstay of treatment
for a gastric ulcer [6]. During the period when histamine-2-
receptor antagonists (H2RAs) were popular, gastric ulcers
that did not healed well after treatment with a standard
dose of H2RA for 12 weeks were termed “intractable” or
“refractory ulcers” [7]. Proton pump inhibitors (PPIs) pro-
vide better healing effects and fewer relapses than H2RA in
managing gastric ulcers [6,8]. However, even after aggres-
sive and prolonged treatment with PPI, not all gastric ulcers
heal completely [5,9]. Even after removing noxious envi-
ronmental agents, poor healing of benign gastric ulcers can
still be observed in certain circumstances [5,10]. The
pathogenesis of this delayed healing response is not well
understood. Transforming growth factor-b (TGF-b) and its
receptors were found to be strongly expressed in well-
healed ulcers but they were downregulated in half of the
refractory gastric ulcers. In the other half of the refractory
gastric ulcers, TGF-b was still normally expressed in the
mucosa [11]. Factors other than growth factors may play a
role in the healing process of a gastric ulcer.
Gap junction intercellular communication is crucial in
diverse cellular processes such as homeostasis, morpho-
genesis, cell differentiation, and growth regulation.
Communication spreads through gap junctional channels
constructed by a family of connexin proteins [12]. Con-
nexins are associated with a wide range of biological
functions from providing restitution following cell damage
to maintaining the integrity of the gastric mucosa [13]. Gap
junction proteins in the gastric mucosa have been associ-
ated with several pathological states of the stomach,
including intestinal metaplasia and gastric carcinoma
[14,15]. A decrease in gap junctions has also been observed
in the active stage of human gastric ulcers [16].
Connexin 32 (Cx32) is among the major gap junction
proteins expressed in the gastric mucosa. Few studies have
examined the role of Cx32 in the healing process of gastric
ulcers. It is decreased or absent during the active stage of
the ulcers, but its reappearance is reported to be related to
the healing of gastric ulcers [17,18]. The role of gap junc-
tions when gastric ulcers persist, however, remains unclear.
The purpose of this study was to investigate the associationof Cx32 expression between different healing responses of
gastric ulcers. The expression level of Cx32 was compared
between normally healed gastric ulcers and those with
delayed healing.
Methods
Patients
From May 2007 to November 2008, patients with spontane-
ously developed gastric ulcers were recruited. The ulcers
were documented by a standard procedure of upper
gastrointestinal endoscopy. Patients were excluded if ulcers
were related to malignancy, gastrinoma, ZollingereEllison
syndrome, or opportunistic infection bymicroorganisms such
as a virus or fungus, which was confirmed by standard his-
tological procedures. Patients were treated with a standard-
dose PPI (e.g., lansoprazole 30 mg daily, pantoprazole 40 mg
daily, or rabeprazole 20 mg daily) for 12 weeks, and
compliancewas ensured. At the end of the treatment period,
a repeat endoscopywas performed to evaluate the healing of
the gastric ulcer. Patients with a gastric ulcer that did not
heal after the 12-week treatment period were assigned to
the delayed healing group, whereas patients with a gastric
ulcer that healed completely were used as controls and
assigned to the normal healing group. Patient histories were
reviewed in detail for age, sex, concomitant use of NSAIDs
including aspirin, and current smoking or alcohol consump-
tion. The study protocol was approved by the Institutional
Review Board of Mackay Memorial Hospital, Taipei, Taiwan.
All patients providedwritten informedconsent and agreed to
be enrolled.
Endoscopic examination and histologic studies
An upper gastrointestinal endoscopic examination was
performed, and the endoscopic findings were evaluated by
experienced endoscopists. The location and size of gastric
ulcers were recorded. The endoscopic staging of gastric
ulcers was evaluated. Biopsies were taken from the mucosa
of the ulcer margin using biopsy forceps at the first endo-
scopic examination in both study groups. The specimens
subjected to histological analysis were fixed in 4% para-
formaldehyde in 0.1M phosphate buffer. Tissues were then
embedded in paraffin and sectioned. Histological sections
were stained with hematoxylin and eosin. Detailed malig-
nancy surveillance was performed carefully, and tissue
sections were also subjected to modified Giemsa staining to
detect the presence of H. pylori. Immunochemical analysis
was then performed on paraffin-embedded sections.
Table 1 Patient demographics and endoscopic features of
the gastric ulcers.
Variable Normal
healing
(N Z 11)
Delayed
healing
(N Z 10)
p
Age (y) 60.2  16.7 66.9  14.5 0.26
Female sex 3 (27.3) 3 (30) 1.00
Gastric ulcer
Size (mm) 9.09  5.15 9.10  4.75 0.83
Location Antrum 7 (63.6) 6 (60) 1.00
Angle 4 (36.4) 3 (30)
Body 0 (0) 1 (10)
Staging A1 3 (27.3) 2 (20) 0.82
A2 4 (36.4) 2 (20)
H1 3 (27.3) 4 (40)
H2 1 (9.1) 2 (20)
Presence
of DU
3 (27.3) 4 (40) 0.66
Data are presented as n (%) or mean  standard deviation.
DU Z duodenal ulcer.
Figure 1 Histological examination of specimens taken from
the ulcer margin show a similar morphology of the gastric
mucosa in the (A) normal and (B) delayed healing groups. He-
matoxylin and eosin stain, 200.
Cx32 and delayed healing of gastric ulcer 69Specimens subjected to immunoblotting were frozen in
liquid nitrogen.
Immunohistochemical analysis
After deparaffinization and hydrating slides with distilled
water, antigen retrieval was performed by microwaving the
slides with antigen unmasking solution (Vector Laboratories,
Burlingame, CA,USA) for 10minutes. Endogenous peroxidase
activity was inactivated by treatment with 3% H2O2. The
slides were blocked with 0.005 g/mL bovine serum albumin
(BSA) for 15 minutes and Cx32 was detected with primary
antibodies specific for this protein (1:50; Zymed, San Fran-
cisco, CA, USA). The slides were further incubated with
biotin-conjugated secondary antibodies for 45 minutes, fol-
lowed by a 30-minute incubation with horseradish perox-
idaseestreptavidin solution (Sigma-Aldrich, St. Louis, MO,
USA). Immunoreactivity was visualized using peroxidase
substrate solution (Vector Laboratories) according to the
manufacturer’s instruction. All these procedures were con-
ducted at room temperature. Sections were stained with
hematoxylin as the counterstain.
Western blot analysis
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) has
been described as a stably expressed gene in the gastric
tissues, and in this study, it was used as an internal control
to study the expression of Cx32. The samples obtained in
the previous section were homogenized and lysed using a
Bullet Blender (Next Advance) with SB-20 buffer [0.69 mol/
L sodium dodecyl sulfate (SDS), 10mM EDTA, 100mM
TriseHCl, pH 6.8] as previously reported [19]. Protein
concentrations were determined with a modified Lowry
method DC (detergent compatible) protein assay kit (Bio-
Rad Laboratories, Hercules, CA, USA). Approximately 30 mg
of cell lysate from each sample was loaded into 10%
SDSepolyacrylamide gels, electrophoresed, and trans-
blotted onto polyvinylidene difluoride membranes (Perki-
nElmer, Zaventem, Belgium). The blots were blocked with
0.1 g/mL BSA for 1 hour and detected with primary anti-
bodies specific for Cx32 (Zymed) at 1:500 dilutions. The
blots were further incubated with alkaline phosphatase-
conjugated secondary antibodies for 1 hour at room tem-
perature. The blots were then stripped with a stripping
buffer (69mM SDS, 100mM 2-mercaptoethanol, 93.75mM
TriseHCl, pH 6.8) at 56C, and incubated with antibodies
against GAPDH diluted at 1:20,000 (Chemicon, Temecula,
CA, USA). Immunoreactivity was visualized using VisioGlo
reagent (AMRESCO, Solon, OH, USA) according to the
manufacturer’s instructions. The one-dimensional gel
analysis of photodensity was performed using TotalLab
software (Nonlinear Dynamics, Newcastle upon Tyne, UK).
The expression of Cx32 was compared with that of GAPDH.
Statistical analysis
We compared the sex of the patient, location and staging of
gastric ulcer, active use of NSAIDs, current smoking or
alcohol consumption, and presence of H. pylori between
the control and study groups using Fisher’s exact test. Age
Table 2 Association of healing response and known fac-
tors related to chronic gastric ulcers.
Factors Normal
healing
(N Z 11)
Delayed
healing
(N Z 10)
p
Helicobacter
pylori infection
5 (54.5) 5 (50) 1.00
NSAID 3 (27.3) 2 (20) 1.00
Smoking 3 (27.3) 4 (40) 0.66
Alcohol 1 (9.1) 2 (20) 0.59
Data are presented as n (%).
NSAID Z nonsteroidal anti-inflammatory drug.
70 S.-Y. Wang et al.and the size of gastric ulcer were compared between the
two groups using Wilcoxon rank sum test. Analysis of the
relative expression of Cx32 between the normal and
delayed healing groups was conducted with one-way anal-
ysis of variance. Correlations between age and the relative
expression of Cx32 were evaluated using linear regression
analysis. All statistical analyses described were performed
using the IBM SPSS Statistics for Windows, version 20.0 (IBM,
Armonk, NY, USA). Statistical significance was defined at a
two-tailed p < 0.05 in all analyses.
Results
Patient characteristics and features of the gastric
ulcers
A total of 2076 upper gastrointestinal endoscopic exami-
nations were performed during the study period, and 477
patients were diagnosed with gastric ulcers. A total of 18
patients had gastric ulcers that showed delayed healing. Of
these, 10 agreed to participate in the study and were
assigned to the delayed healing group. A corresponding
group of patients (n Z 11) with a normal healing response
of their gastric ulcers were included in the study as con-
trols. Table 1 summarizes the patient characteristics and
the endoscopic findings of the two groups. The age and sexTable 3 Influence of factors on the relative expression of conn
Relative Cx32 expre
Yes
Gastric ulcer
Delayed healing 0.803  0.192 (10)
Size (>1 cm) 0.939  0.245 (5)
Antral ulcer 0.925  0.197 (13)
Active stage 0.936  0.221 (11)
Duodenal ulcer 0.920  0.223 (7)
Helicobacter pylori infection 1.006  0.403 (10)
NSAID 0.880  0.142 (5)
Smoking 1.001  0.227 (7)
Alcohol 0.949  0.281 (3)
Data are presented as mean  standard deviation.
Cx32 Z connexin 32; GAPDH Z glyceraldehyde 3-phosphate dehydrodistribution, location and size of gastric ulcers, endoscopic
staging of ulcers, and presence of duodenal ulcers are
similar between the normal and delayed healing groups (all
p > 0.2; Table 1).
Submucosal tissue was virtually invisible in histological
sections regardless of the group. The ratio of the gastric
epithelium to the stroma in the gastric mucosa from either
the controls or the ulcers with delayed healing was com-
parable (Fig. 1). Hemorrhages in tissue and crushing arti-
facts related to biopsy were limited.
Healing response and known factors associated
with chronic gastric ulcers
Several proposed factors found to be relevant to chronic
gastric ulcers in previous studies were compared between
the two groups of patients (Table 2). H. pylori infection was
detected in more than half of the patients in each group.
No less than 20% of patients in each group had recent use of
NSAID, including aspirin. Less than 50% of patients reported
cigarette smoking and <25% of patients reported alcohol
consumption in both groups. All the differences were not
significantly different (all p > 0.5).
Expression of Cx32 in the gastric mucosa
The expression level of Cx32was calibrated using the level of
GAPDH, and the results are presented in Table 3. Sex did not
influence Cx32 expression (male, 0.92  0.251; female,
1.043  0.499; p Z 0.46). Presence of duodenal ulcers, H.
pylori infection, use of NSAIDs, cigarettes use, and alcohol
consumption also did not have a statistically significant
impact on the expression level of Cx32 in the gastric mucosa
of the ulcer margin. By separating recent use of aspirin from
NSAID use, it was found that two patients in the control group
and none in the delayed healing group had used aspirin, but
the difference between groups was not statistically signifi-
cant (pZ 0.16). Moreover, by analyzing the patients without
aspirin use, the relative expression of Cx32 had a wider
margin between the normal and delayed healing groups
(normal healing: Cx32/GAPDH, 1.143  0.400; delayedexin 32 in the gastric mucosa.
ssion (Cx32/GAPDH)  (no. of patients) p
No
1.093  0.376 (11) 0.04
0.960  0.360 (16) 0.91
1.003  0.492 (8) 0.61
0.976  0.433 (10) 0.79
0.973  0.380 (14) 0.74
0.909  0.259 (11) 0.52
0.979  0.372 (16) 0.58
0.932  0.378 (14) 0.67
0.956  0.346 (18) 0.97
genase; NSAID Z nonsteroidal anti-inflammatory drug.
Cx32 and delayed healing of gastric ulcer 71healing: Cx32/GAPDH, 0.803  0.192). The expression of
Cx32 was not correlated with the age of the patients
(pZ 0.79).
Fig. 2 shows a comparison of Cx32 and GAPDH expres-
sions between the normal and delayed healing groups.
Cx32 expression was downregulated in the gastric mucosa
near the poorly healed gastric ulcer. As a consequence, the
relative expression level of Cx32 in the delayed healing
group was significantly reduced (p Z 0.04, Fig. 2B). The
GAPDH levels were similar between the two groups.
Immunohistochemical analysis of Cx32 revealed that Cx32
was mainly distributed in the gastric mucosa instead of
stroma (Fig. 3). Higher expression of Cx32 was noted in the
gastric mucosa of the normally healed gastric ulcer
(Fig. 3).Discussion
In this study, we showed that in patients with gastric ulcer,
at the end of standard-dose PPI treatment for 12 weeks,
the expression of Cx32 in the gastric mucosa at the margin
of persistent ulcers was reduced, although no significantA
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Figure 2 (A) Comparison of the expression of connexin 32
(Cx32) between the gastric mucosa in the normal and delayed
healing groups using Western blotting. Note that GAPDH was
used as an internal control. (B) Analysis of Cx32 expression in
the gastric mucosa of the normal and delayed healing groups.
The expression level is shown as a ratio of the Cx32 signal to
the GAPDH signal. The length of boxes represents the inter-
quartile range and the thick lines show medians. *p < 0.05
compared with controls. GAPDH Z glyceraldehyde 3-
phosphate dehydrogenase.differences were observed regarding the clinical de-
mographics and known environmental factors associated
with gastric ulcers between the normal and delayed healing
groups. This novel finding helps to understand the healing
of gastric ulcers.
The physiological role of Cx32 in the human stomach is
still not fully understood. One of its potential functions is to
facilitate the transfer of messages along the gland axis,
leading to synchronized cellular activation and acid secre-
tion [20]. In a rat model of acetic acid-induced gastric ul-
cers, compared with the untreated animals, Cx32 appeared
earlier in the cimetidine-treated animals, in which the ul-
cers healed earlier [17]. Our finding in the present study
that Cx32 is downregulated in the poorly healed ulcers is
consistent with the results of the animal study mentioned
earlier [17]. This finding suggested that Cx32 may play an
important role in host factors determining the integrity of
the gastric mucosa.
Malignant cells in gastric carcinoma show an absence of
Cx32 expression [15]. The loss of intercellular communica-
tion is thought to signify lost capability to curbing early
carcinogenesis [21]. The persistence of gastric ulcers usu-
ally raises concerns of neoplastic changes. Despite delayed
healing responses, samples taken from the ulcer margin by
biopsy in this study exhibited no histological evidence of
malignant or dysplastic changes. Although by endoscopic
observation the patients in the delayed healing group had
incomplete reinstituted gastric epithelium on the ulcer at
up to 1.5 years in the study period, there was no evidence
of malignancy. It may be worth studying the effects of
reduced expression of Cx32 in the development of gastric
cancer from unhealed ulcers.
Water extracts of H. pylori, especially the cytotoxin-
associated antigen A (CagA)-positive strain, are reported
to delay the appearance of Cx32 during the healing of
acetic acid-induced gastric ulcers in rats [22]. More recent
evidence, however, has shown that H. pylori migrates to
the intercellular space and disrupts tight junctions by
introducing CagA into the gastric epithelium [23]. In our
previous report, the disruption of intercellular tight junc-
tions instead of gap junctions was associated with the
persistence of the gastric ulcer and H. pylori infection [24].
Because the prevalence of H. pylori infection was similar
between the groups in this study, the reduction in Cx32
expression is unlikely owing to the invasiveness of H.
pylori.
The major limitation of our study was the small sample
size and the caseecontrol design. A previous study
including 150 patients with acid peptic disease refractory
to H2RA found that only three of 16 patients had persistent
gastric ulcers after a 12-week treatment with a PPI [4].
The low prevalence of poorly healed gastric ulcers makes a
large study population difficult. PPIs are potent inhibitors
of gastric acid secretion, and such strong acid inhibition
may overshadow the impact of exogenous environmental
factors, making difference between the groups less
evident for nondominant factors, especially in a small
sample size. This may therefore explain that the exoge-
nous factors previously reported to be associated with
chronic gastric ulcers did not show a strong association to
the healing response of gastric ulcers following PPI
treatment.
Figure 3 Immunohistochemical analysis of connexin 32 in the gastric mucosa of the normal and delayed healing groups. (A) 20,
normal healing; (B) 40, normal healing; (C) 20, delayed healing; and (D) 40, delayed healing.
72 S.-Y. Wang et al.Conclusion
Cx32 expression in the gastric mucosa was downregulated
in gastric ulcers that showed delayed healing. Intercellular
communication through Cx32 gap junctions may be a
pivotal host factor in the healing of gastric ulcer. The
downregulation of Cx32 in the gastric ulcers may be pre-
dictive of their refractoriness to standard acid-suppression
therapies and may be of value for the development of
auxiliary treatments for gastric ulcers.
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